healthcare News

Mental Health Stocks Gain as HHS Scraps $2B Funding Cut
Healthcare
2mo ago

Mental Health Stocks Gain as HHS Scraps $2B Funding Cut

The abrupt reversal of cuts to substance abuse and mental health grants provides critical financial relief for care providers, boosting investor confidence.

UnitedHealth Stock Dips on Scathing Senate Medicare Report
Healthcare
2mo ago

UnitedHealth Stock Dips on Scathing Senate Medicare Report

An investigation by a U.S. Senate committee alleges the insurance giant used 'aggressive' tactics to boost payments from the federal government's Medicare Advantage program, intensifying regulatory pressure.

Inogen Stock Slides After Q4 Revenue Falls 11% Short of Estimates
Healthcare
2mo ago

Inogen Stock Slides After Q4 Revenue Falls 11% Short of Estimates

Company cites delayed customer orders for the significant revenue miss and declines to issue a financial forecast for 2026, creating investor uncertainty.

Senseonics Surges on Major Q4 Revenue Beat, Strong 2026 Outlook
Healthcare
2mo ago

Senseonics Surges on Major Q4 Revenue Beat, Strong 2026 Outlook

The diabetes tech firm's preliminary revenue beat estimates by over 78%, signaling growing traction for its long-term implantable glucose monitor.

BioLife Solutions Misses Q4 Revenue Due to Pull-Forward, Beats Full-Year Target
Healthcare
2mo ago

BioLife Solutions Misses Q4 Revenue Due to Pull-Forward, Beats Full-Year Target

The biopreservation tool supplier reported 20% year-over-year quarterly growth and record full-year sales, citing a customer request for an earlier shipment for the fourth-quarter miss.

Cerus Corp Lifts 2026 Forecast on Strong Blood Product Demand
Healthcare
2mo ago

Cerus Corp Lifts 2026 Forecast on Strong Blood Product Demand

Biomedical firm posts 14% revenue growth in preliminary 2025 results, beating Q4 estimates and signaling continued momentum for its blood safety system.

Harmony Biosciences Jumps After Strong 2026 WAKIX Revenue Forecast
Healthcare
2mo ago

Harmony Biosciences Jumps After Strong 2026 WAKIX Revenue Forecast

The biotech company projects its key narcolepsy drug, WAKIX, will surpass $1 billion in annual revenue, signaling robust long-term growth and boosting investor confidence.

AtriCure Jumps After Strong Revenue Beat, New Credit Facility
Healthcare
2mo ago

AtriCure Jumps After Strong Revenue Beat, New Credit Facility

The medical device maker announced preliminary Q4 revenue ahead of estimates and secured a new $125 million credit agreement, signaling strong operational and financial health.